Title:
The 4th Annual Conference in Japan for Asian New Drug Development
Date(s) And Time(s):
Apr 13 2010 9:00AM - Apr 14 2010 5:30PM
Location:
Tower Hall Funabori
4-1-1 Funabori
Edogawa-ku
Tokyo
134-0091 Japan
Overview:
OVERVIEW
The third conference for Asian new drug development was held in Tokyo in May, 2009. Several issues about Asian development were discussed intensively from the sponsor’s and the regulatory reviewer’s point of view.
For the fourth conference, the program committee has been joined by colleagues from East Asian countries – China, the Republic of Korea, Taiwan, and Japan – who are actively involved in drug development in Asia. The more critical topics have been selected.
Main topics are as follows:
1) Asian clinical trials in oncology area (development strategy and operation)
2) Simultaneous global development from East Asia point of view
3) Ethnic similarity and differences among East Asia (medical practices, PK etc.)
Several experts in drug development from China, the Republic of Korea, Taiwan, and Japan will share their experiences and discuss how we can contribute to healthcare and the patients in Asia. We are also planning for opportunities for substantive discussion with PMDA regulators in order to develop new drugs which contribute to public health.
Target Audience:
This program will benefit the following individuals:
· Clinical development professionals
· Personnel involved in regulatory affairs
· Personnel at clinical study sites
· Personnel at CROs and SMOs
Event Code:
10302
Contact Information:
For meeting and tabletop exhibit information, contact Keiko Cambridge at the Drug Information Association, LLC office in Tokyo by:
Telephone: +81-3-5833-8444
Fax: +81-3-5820-8448 /
email: keiko.cambridge@diajapan.org
|